News
Coca-Cola (KO) Earnings Expected to Grow: Should You Buy?
Coca-Cola (KO) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook
Philip Morris (PM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Philip Morris (PM) reports results for the quarter ended September 2025. While this widely-known consensus outlook
Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for
The market expects Elevance Health (ELV) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Chubb (CB) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Chubb (CB) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
GE Aerospace (GE) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when GE Aerospace (GE) reports results for the quarter ended September 2025. While this widely-known consensus outlook
General Motors (GM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
General Motors (GM) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook
SmarFinancial (SMBK) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when SmarFinancial (SMBK) reports results for the quarter ended September 2025. While this widely-known consensus
Earnings Preview: Manhattan Associates (MANH) Q3 Earnings Expected to Decline
Manhattan Associates (MANH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Nasdaq (NDAQ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Nasdaq (NDAQ) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Earnings Preview: Matador Resources (MTDR) Q3 Earnings Expected to Decline
The market expects Matador Resources (MTDR) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Citigroup (C) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended September 2025, Citigroup (C) reported revenue of $22.09 billion, up 8.7% over the same period last year. EPS came in at $2.24, compared to $1.51 in the year-ago quarter.
The
Best Momentum Stock to Buy for Oct. 14th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Oct. 14th:
HudBay Minerals HBM: This mining company, which is engaged in discovery
Wall Street Analysts Believe Relay Therapeutics (RLAY) Could Rally 116.91%: Here's is How to Trade
Shares of Relay Therapeutics, Inc. (RLAY) have gained 54.4% over the past four weeks to close the last trading session at $6.27, but there could still be a solid upside left in the stock if
Wall Street Analysts Believe Mobileye (MBLY) Could Rally 25.86%: Here's is How to Trade
Shares of Mobileye Global (MBLY) have gained 10.2% over the past four weeks to close the last trading session at $15.2, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Predict a 30.28% Upside in Kodiak Gas (KGS): Here's What You Should Know
Kodiak Gas Services (KGS) closed the last trading session at $34.05, gaining 2.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Think Kiniksa Pharmaceuticals International, plc (KNSA) Could Surge 29.3%: Read This Before Placing a Bet
Shares of Kiniksa Pharmaceuticals International, plc (KNSA) have gained 1.3% over the past four weeks to close the last trading session at $37.03, but there could still be a solid upside left in the
Does Kamada (KMDA) Have the Potential to Rally 114.39% as Wall Street Analysts Expect?
Kamada (KMDA) closed the last trading session at $6.88, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Princeton Bancorp (BPRN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
A downtrend has been apparent in Princeton Bancorp (BPRN) lately. While the stock has lost 7.9% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed in
Here's Why Bank of Marin (BMRC) Looks Ripe for Bottom Fishing
The price trend for Bank of Marin (BMRC) has been bearish lately and the stock has lost 5% over the past four weeks. However, the formation of a hammer chart pattern in its last trading session
Wall Street Analysts Predict a 36.47% Upside in Select Medical (SEM): Here's What You Should Know
Shares of Select Medical (SEM) have gained 7.8% over the past four weeks to close the last trading session at $13.19, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Predict a 42.77% Upside in DarioHealth (DRIO): Here's What You Should Know
DarioHealth Corp. (DRIO) closed the last trading session at $14.94, gaining 124% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Does Byrna Technologies (BYRN) Have the Potential to Rally 65.23% as Wall Street Analysts Expect?
Shares of Byrna Technologies Inc. (BYRN) have gained 22.8% over the past four weeks to close the last trading session at $24.59, but there could still be a solid upside left in the stock if
Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 241.59%: Read This Before Placing a Bet
Day One Biopharmaceuticals, Inc. (DAWN) closed the last trading session at $7.19, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Fiverr (FVRR) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
The price trend for Fiverr International (FVRR) has been bearish lately and the stock has lost 5.8% over the past week. However, the formation of a hammer chart pattern in its last trading session
Fox (FOX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
A downtrend has been apparent in Fox Corporation (FOX) lately. While the stock has lost 5.7% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last